King of Prussia, PA, United States of America

Richard N Hjorth

This inventor holds 3 USPTO granted patents. Top assignee: American Home Products Corporation. Active years: 1984-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard N Hjorth. Retrieved from https://idiyas.com/inventor/richard-n-hjorth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.3

ph-index = 3

Forward Citations = 50(Granted Patents)


Company Filing History:


Years Active: 1984-1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Richard N Hjorth: Innovator in Vaccine Adjuvants

Introduction

Richard N Hjorth is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of vaccine development, particularly in the area of adjuvants for viral vaccines. With a total of 3 patents to his name, Hjorth's work has the potential to enhance the efficacy of vaccines.

Latest Patents

Hjorth's latest patents focus on innovative adjuvant compositions for mammalian vaccines. One of his inventions discloses vaccine compositions that include an effective amount of an adjuvant comprising squalene or squalane, glycerol, and a surfactant. These compositions may also optionally contain an aluminum salt and one or more pharmaceutically acceptable buffers. Another patent similarly reveals vaccine compositions with an adjuvant that includes squalene or squalane, along with one or more phospholipids and a surfactant, also allowing for the inclusion of aluminum salts and buffers.

Career Highlights

Richard N Hjorth is associated with American Home Products Corporation, where he has been able to apply his expertise in vaccine technology. His work has contributed to advancements in the field, particularly in improving vaccine formulations.

Collaborations

Hjorth has collaborated with notable colleagues such as Bobby O Moore and Norman H Grant. Their combined efforts have likely played a role in the development of innovative solutions in vaccine technology.

Conclusion

Richard N Hjorth's contributions to vaccine adjuvants represent a significant advancement in immunology. His patents reflect a commitment to enhancing vaccine efficacy, which is crucial for public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…